Sub-Micromolar Inhibition of SARS-CoV-2 3CLpro by Natural Compounds

Bruno Rizzuti,Laura Ceballos-Laita,David Ortega-Alarcon,Ana Jimenez-Alesanco,Sonia Vega,Fedora Grande,Filomena Conforti,Olga Abian,Adrian Velazquez-Campoy
DOI: https://doi.org/10.3390/ph14090892
IF: 4.6
2021-09-01
Pharmaceuticals
Abstract:Inhibiting the main protease 3CLpro is the most common strategy in the search for antiviral drugs to fight the infection from SARS-CoV-2. We report that the natural compound eugenol is able to hamper in vitro the enzymatic activity of 3CLpro, the SARS-CoV-2 main protease, with an inhibition constant in the sub-micromolar range (Ki = 0.81 μM). Two phenylpropene analogs were also tested: the same effect was observed for estragole with a lower potency (Ki = 4.1 μM), whereas anethole was less active. The binding efficiency index of these compounds is remarkably favorable due also to their small molecular mass (MW < 165 Da). We envision that nanomolar inhibition of 3CLpro is widely accessible within the chemical space of simple natural compounds.
pharmacology & pharmacy,chemistry, medicinal
What problem does this paper attempt to address?